4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Digital health for geriatric oncology
    Journal Article

    Fallahzadeh, R.; Rokni, S. A.; Ghasemzadeh, H.; Soto-Perez-de-Celis, E.; Shahrokni, A.
    JCO Clinical Cancer Informatics (2018)

    Fulltext@MSK | Save
  • PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling
    Meeting Abstract

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; Torres, N.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Analysis of cell-free plasma DNA to identify tumors with microsatellite instability and exceptionally high tumor mutation burden in patients treated with PD-1 blockade
    Meeting Abstract

    Georgiadis, A.; Durham, J. N.; Keefer, L.; Bartlett, B. R.; Zielonka, M.; Murphy, D.; White, J. R.; Lu, S.; Verner, E.; Ruan, F.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • A simple geriatric vulnerability index for older patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P. B.; Perales, M. A.; Tamari, R.; Shaffer, B. C.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Rivaroxaban thromboprophylaxis in high risk ambulatory cancer patients receiving systemic therapy: Results of a randomized clinical trial (CASSINI)
    Meeting Abstract

    Khorana, A. A.; Soff, G. A.; Kakkar, A. K.; Vadhan-Raj, S.; Riess, H.; Wun, T.; Streiff, M. B.; Garcia, D. A.; Liebman, H. A.; Belani, C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions
    Meeting Abstract

    Javle, M.; Kelley, R. K.; Roychowdhury, S.; Weiss, K. H.; Abou-Alfa, G. K.; Macarulla, T.; Sadeghi, S.; Waldschmidt, D.; Zhu, A. X.; Goyal, L.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Interim results of fight-202, a phase II, open-label, multicenter study of INCB054828 in patients (pts) with previously treated advanced/metastatic or surgically unresectable cholangiocarcinoma (CCA) with/without fibroblast growth factor (FGF)/FGF receptor (FGFR) genetic alterations
    Meeting Abstract

    Hollebecque, A.; Borad, M.; Sahai, V.; Catenacci, D. V. T.; Murphy, A.; Vaccaro, G.; Paulson, A.; Oh, D. Y.; FeĢliz, L.; Lihou, C.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Assessment of disease burden in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Blanc, J. F.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Cicin, I.; Chen, Y.; Bolondi, L.; Dadduzio, V.; Baron, A.; Lin, Z. Z.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer
    Meeting Abstract

    Bang, Y. J.; Van Cutsem, E.; Fuchs, C. S.; Ohtsu, A.; Tabernero, J.; Ilson, D. H.; Hyung, W. J.; Strong, V. E.; Goetze, T. O.; Yoshikawa, T.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save